January 23, 2021

Volume XI, Number 23

Advertisement

January 22, 2021

Subscribe to Latest Legal News and Analysis

January 21, 2021

Subscribe to Latest Legal News and Analysis

January 20, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
17
Jun
Colorado High Court Deems Use of Legal Marijuana Valid Ground for Termination Steptoe & Johnson PLLC
17
Jun
Federal Circuit Invalidates Sequenom’s Fetal DNA Prenatal Diagnosis Patent as Not Patent Eligible Barnes & Thornburg LLP
17
Jun
UPDATE: FDA Announces Decision on Trans Fats Schiff Hardin LLP
17
Jun
Proposed Rules Released Covering 340B Ceiling Prices and Manufacturer Penalties McDermott Will & Emery
17
Jun
Colorado Employers Can Fire Workers for Off-Duty Medical Marijuana Use Armstrong Teasdale
17
Jun
Off-Duty Medical Marijuana Use Held Permissible Basis to Terminate Employment Schiff Hardin LLP
16
Jun
As Bird Flu Looms, USDA Takes Steps to Facilitate Egg Imports Processes Morgan, Lewis & Bockius LLP
16
Jun
FDA Gives Three Years to Eliminate Use of Artificial Trans Fats in Processed Foods Michael Best & Friedrich LLP
16
Jun
Colorado Supreme Court Holds Medical Use of Marijuana is Not “Lawful”; Upholds Employee Discharge For Positive Drug Test Jackson Lewis P.C.
16
Jun
Federal Circuit: Sequenom’s Diagnostic Method Claims Invalid Under §101 Mintz
15
Jun
Colorado Supreme Court Confirms Employers May Fire Employees for Medical Marijuana Use Squire Patton Boggs (US) LLP
15
Jun
China Removes Price Ceilings from Most Drugs McDermott Will & Emery
15
Jun
Federal Circuit Hold Sequenom Diagnostic Method Patent Invalid Under 101 Foley & Lardner LLP
15
Jun
Ariosa Diagnostics, Inc. v. Sequenom, Inc. – Another Diagnostic Patent Meets its End Michael Best & Friedrich LLP
13
Jun
Michigan Department of Environmental Quality Announces Concentrated Animal Feeding Operations Permit Change to Protect Michigan Surface Waters Varnum LLP
12
Jun
Ariosa v. Sequenom – Novel Genetic Analysis Fails The Mayo Test Schwegman, Lundberg & Woessner, P.A.
12
Jun
General Court Confirms Market Exclusivity Rights in CTRS Case Covington & Burling LLP
12
Jun
Food Service Company Settles Whistleblower Suit Alleging Overcharging and Poor Performance of Contracts with DC School System for $19.4 Million Morgan, Lewis & Bockius LLP
12
Jun
Louisiana Employers May Use Hair To Test For Drugs Jackson Lewis P.C.
12
Jun
New Draft EMA-Guideline On Clinical Development Of Fixed Combination Medicines Covington & Burling LLP

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement